| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Hostile Work Environments - Escalating Conflict and What You Can Do About It |
|
Advice You - Hostile Work Environments - Escalating Conflict and What You Can Do About It
Not all conflict is negative. Conflict, when understood as a difference of wants, needs, or expectations, can be the catalyst for new discoveries, innovative collaborations, and unique solutions to seemingly insurmountable problems. While conflict has the potential for promoting creativit According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product y and innovation, it is also a significant contributing factor to low workplace morale, employee disengagement, stress, and physical illness. Left unaddressed, conflict can have a devastating effect on the work environment. Knowing when to intervene is the key to minimizing the negative e ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in fects of conflict and maximizing its positive potential. Conflict, at its very beginning, is at the productive stage. Although individuals may have a difference of opinion about a situation or issue, when those differences are shared and discussed, there is opportunity for new insi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hts, greater understanding, and dynamic solutions. At this point, conflict can be productive. But there are two requirements of the individuals involved in the conflict - they must be willing to address the issue and they must be able to talk with one another. When conflict remains at thi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe productive stage, intervention by a third party is not required. The disputants themselves will work together to find an acceptable solution. When, however, the parties are either not willing to address the conflict or are unable to talk together, the conflict is likely to escalate to th d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro personalized stage. At this stage, the parties involved in the conflict lose sight of the particular issue or event that initiated the dispute. Their focus turns more personal and they begin to see the other party as the "real problem." Comments become more targeted against the oth ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc r - it's because the other party is stubborn, or unreasonable, that they cannot find a solution to the conflict. The disputants are likely to pick up on each others' faults in other aspects of their work relationship as well ("I knew she was power-hungry as soon as she took the lead on tha easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi last project. She's never happy with anything I do.") to the point where the conflict encompasses numerous issues and events. It is at this stage of conflict that intervention becomes imperative. When disputing parties are unable to talk together, a third party can assist them in address nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ng the conflict. In the workplace, this can mean a number of things. A manager, supervisor, or HR staff, may work as a coach, talking with the parties individually to help them articulate their issues and explore options for resolution. Disputants may need coaching on how to communicate th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ir needs or expectations in a manner that promotes understanding rather than adding fuel to the fire. Or the disputants may require a neutral third party to facilitate a discussion of their differences. This neutral third party would serve as a mediator, ensuring that the discussion remain ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi focused on the issues so that the parties can move towards resolution. Left unresolved at the personalized stage, conflict will continue to escalate to the hostile stage. It is at this point that other people become involved in the conflict. When individual and personal annoyances ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a between the disputants continue unabated, the parties begin to seek justification for their frustration by talking about the situation with other people. And, whether other parties take sides or attempt to remain neutral, they become part of a larger dynamic. Assumptions are made about who dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod is taking sides, or about why one disputant is being supported while another is not. An atmosphere of mistrust and suspicion begins to affect everyone. Eventually, the conflict will culminate at the polarized stage. It is at this stage that sides in the conflict are clearly defined cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin There is no trust or interaction between the two sides. All communication has completely broken down. Workflow is significantly interrupted, as there is complete lack of cooperation between the disputing parties. In the workplace, a conflict at this stage usually results in a situation th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t is so difficult and uncomfortable that one or both parties leaves the organization. Conflict can be resolved at the hostile and polarized stage. But it becomes increasingly difficult. When conflicts have escalated to the hostile or polarized stage, it is often impossible to discern exac t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ly how or where the conflict even began. More people are involved in the situation. Positions have become more entrenched. Patterns of miscommunication and mistrust have intensified. Assistance from a neutral third party is required to help the parties consider how to move forward and find ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust opportunities to work together. Because the conflict has escalated and evolved, intervention necessitates skill and experience in dealing with intensive resolution processes. Resolution of conflict at the hostile or polarized stage is complicated and time consuming. Some managers may have y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products the skills required and feel comfortable with addressing conflict at this level. Others will not. But, regardless of skill level, even if the manager accesses outside assistance, dealing with this level of conflict will monopolize the manager's workday for weeks, and sometimes months, at a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de time. Managers will always be required to deal with conflict. Are managers typically spending too much or too little time on conflict? It al depends on when they're addressing the conflict. Allowed to escalate, time requirements for dealing with conflict may become unmanageable and the en elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip result merely satisfactory. But time spent on early conflict resolution is time well spent. It is at the early stages of conflict that resolution can enhance the personal skills of employees, build rapport in the workplace, and harness creative and innovative problem solving opportunities tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Career Change After 50 – A Risk Free Strategy Corporate America's Scary Pension Tactics: Why You Should Look Online To Insure Your Future Develop Learning Potential Through Paired-Learning
|